The effect of seat tube angle at selected seat heights (96, 100 and 104% trochanteric height) on heart rate, VO2 and lower limb kinematics was evaluated in 14 competitive male road racing cyclists during discontinuous submaximal exercise (200 W) on an air-resistance ergometer at seat tube angles of 68, 74 and 80 degrees. The tests were randomized to complete the nine combinations (three seat heights, three tube angles) in opposite directions from a starting tube angle of 74 degrees and 100% trochanteric height to avoid any time or sequence bias. Power efficiency was calculated for each combination from work done and VO2. All results were analysed using ANOVA for repeated measures. At a seat tube angle of 80 degrees, mean VO2 was significantly lower and power efficiency significantly higher compared with an angle of 74 degrees at all three seat heights, while heart rate was significantly lower only at a seat height equal to trochanteric height. At a seat tube angle of 74 degrees, mean VO2 and heart rate were significantly lower and power efficiency significantly higher compared with an angle of 68 degrees at all three seat heights. Hip range of movement and maximum and minimum hip angle were significantly less at an angle of 80 degrees compared with 68 degrees. Further biomechanical analysis suggested that the improvement in cycling efficiency observed at steeper seat tube angles was produced in part by the resultant altered ankling pattern of the cyclist.
Wierwille who was extremely helpful in designing this study' s apparatus, and making sure that all appropriate ethical considerations for the use of human subjects in experiments were carried out. Greatly appreciated were Dr.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.